Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis

Virology Journal

Volumn 3, Issue , 2006, Pages

  El Awady, Mostafa K ^a   El Abd, Yasmine S ^a   Shoeb, Hussein A ^b   Tabll, Ashraf A ^a   Hosny, Alaa El Din M S ^b   El Shenawy, Reem M ^a   Atef, Khaled ^a   El Din, Noha G Bader ^a   Bahgat, Mahmoud M ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBODY; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; DNA; LIVER ENZYME; VIRUS ANTIGEN; VIRUS RNA;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C VIRUS; HUMAN; INFECTION; MAJOR CLINICAL STUDY; VIRUS CORE; VIRUS LOAD; WESTERN BLOTTING;

ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, VIRAL; BASE SEQUENCE; BIOLOGICAL MARKERS; DNA PRIMERS; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL CORE PROTEINS; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 33749410785     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-3-67     Document Type: Article

References (49)

1. Rice CM: Fields Virology Edited by: Fields BN, Knippe DM, Howley PM. Lippincot-Raven; 1996:931-960.
2. Houghton M: Fields Virology Edited by: Fields BN, Knippe DM, Howley PM. Lippincot-Raven; 1996:1035-1058.
3. Oldstone MB: Viral persistence. Cell 1989, 56:517-20.
4. De la Torre JC, Oldstone MB: Anatomy of viral persistence. mechanisms of persistence and associated disease. Adv Virus Res 1996, 46:311-343.
5. Domingo E, Menendez-Arias L, Quinones-Mateu ME, Holguin A, Gutierrez-Rivas M, Martinez MA, Quer J, Novella IS, Holland JJ: Viral quasispecies and the problem of vaccine-escape and drug-resistant mutants. Prog Drug Res 1997, 48:99-128.
6. Eigen M: On the nature of virus quasispecies. Trends Microbiol 1996, 4:212-214.
7. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J: Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992, 66:3225-3229.
8. Bukh J, Miller RH, Purcell RH: Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995, 15:41-63.
9. Hong Z, Beaudet-Miller M, Lanford RE, Guerra B, Wright-Minogue J, Skelton A, Baroudy BM, Reyes GR, Lau JY: Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees. Virology 1999, 256:36-44.
10. Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter HJ, Purcell RH: Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA 1996, 93:15394-15399.
11. Farci P, Bukh J, Purcell RH: The quasispecies of hepatitis C virus and the host immune response. Springer Semin Immunopathol 1997, 19:5-26.
12. Koike K, Moriya K: Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH. J Gastroenterol 2005, 40(4):329-336.
13. Shin JY, Hur W, Wang JS, Jang JW, Kim CW, Bae SH, Jang SK, Yang SH, Sung YC, Kwon OJ, Yoon SK: HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Exp Mol Med 2005, 30; 37(2):138-145.
14. Xue KX: Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis. Ai Zheng 2005, 24(6):757-68.
15. Moatter T, Hussainy AS, Hamid S, Ahmad Z, Siddiqui S: Comparative analysis of viral titers and histologic features of Pakistani patients infected with hepatitis C virus type 3. Int J Infect Dis 2002, 6(4):272-6.
16. Hassan MI, Kassim SK, Ali HS, Sayed el-D A, Khalifa A: Evaluation of nitric oxide (NO) levels in hepatitis C virus (HCV) infection: relationship to schistosomiasis and liver cirrhosis among Egyptian patients. Dis Markers 2002, 18:137-142.
17. Sabin CA, Emery V, Devereux HL, Griffioen A, Bishop J, Dusheiko G, Yee TT, Herrero-Martinez E, Lee CA: Long-term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders. J Med Virol 2002, 68:68-75.
18. McCormick SE, Goodman ZD, Maydonovitch CL, Sjogren MH: Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C. Am J Gastroenterol 1996, 91:1516-22.
19. Trabaud MA, Bailly F, Si-Ahmed SN, Chevallier P, Sepetjan M, Colucci G, Trepo C: Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon. J Med Virol 1997, 52:105-112.
20. Yeo AE, Ghany M, Conry-Cantilena C, Melpolder JC, Kleiner DE, Shih JW, Hoofnagle JH, Alter HJ: Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers. J Viral Hepat 2001, 8:256-63.
21. Tanaka Y, Agha S, Saudy N, Kurbanov F, Orito E, Kato T, Abo-Zeid M, Khalaf M, Miyakawa Y, Mizokami M: Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol 2004, 58:191-5.
22. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
23. Fong TL, Shindo M, Feinstone SM, Hoofnaglen JH, Di Bisceglie AM: Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest 1991, 88:1058-1060.
24. Goergen B, Jakobs S, Symmons P, Hornes E, Meyer zum Buschenfelde KH, Gerken G: Quantitation of HCV-replication using one-step competitive reverse transcription-polymerase chain reaction and a solid phase, colorimetric detection method. J Hepatol 1994, 21:678-682.
25. El-Awady MK, Abdel Rahman MM, Ismail SM, Amr KS, Omran M, Mohamed SA: Prediction of relapse after interferon therapy in hepatitis C virus-infected patients by the use of triple assay. J Gastroenterol Hepatol 2003, 18:68-73.
26. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 1982.
27. Elbeik T, Markowitz N, Nassos P, Kumar U, Beringer S, Haller B, Ng V: Simultaneous runs of the Bayer VERSANT HIV-1 version 3.0 and HCV bDNA version 3.0 quantitative assays on the system 340 platform provide reliable quantitation and improved work flow. J Clin Microbiol 2004, 42(7):3120-7.
28. Lock RJ, Unsworth DJ: Measurement of immune complexes is not useful in routine clinical practice. Ann Clin Biochem 2000, 37(Pt 3):253-261.
29. Juranic Z, Babovic N, Tomasevic Z: Levels of immune complexes in fresh and frozen serum and plasma detected by precipitation with polyethylene glycol in patients with malignant diseases. Srp Arh Celok Lek 1997, 125(5-6):154-156.
30. El Awady MK, El-Demellawy MA, Khalil SB, Galal D, Goueli SA: Synthetic peptide-based immunoassay as a supplemental test for HCV infection. Clin Chim Acta 2002, 325:39-46.
31. Maghraby A, Bahgat M: Immunostimulatory Effect of Coumarin Derivatives Before and After Infection of mice with the Parasite Schistosoma mansoni : In Vivo Study. Drug Research "Arzneimittelforschung" 2004, 54:545-550.
32. Engvall E, Perlman P: Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 1971, 8:871-874.
33. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
34. Hnatyszyn HJ: Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther 2005, 10(1):1-11.
35. Pawlotsky JM: Current and future concepts in hepatitis C therapy. Semin Liver Dis 2005, 25(1):72-83.
36. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K: Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 175:220-228.
37. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, Saracco G, Choo QL, Houghton M: Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991, 180:842-848.
38. Martell M, Gomez J, Esteban JI, Sauleda S, Quer J, Cabot B, Esteban R, Guardia J: High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J Clin Microbiol 1999, 37:327-332.
39. El-Awady MK, Tabll A, EL-Rashdy MR, Youssef S, Omran MH, Thakeb F, EL-Demellawy M: Flow Cytometric detection of hepatitis C virus antigens in infected peripheral blood leucocytes: binding and entry. World J Gastroenterol 2005, 11(33):5203-5208.
40. Orito E, Mizokami M, Tanaka T, Lau JY, Suzuki K, Yamauchi M, Ohta Y, Hasegawa A, Tanaka S, Kohara M: Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes. Gut 1996, 39:876-880.
41. Dickson RC, Mizokami M, Orito E, Qian KP, Lau JY: Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C. Clinical and virologic implications. Transplantation 1999, 68:1512-1516.
42. Maynard M, Pradat P, Berthillon P, Picchio G, Voirin N, Martinot M, Marcellin P, Trepo C: Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy. J Viral Hepat 2003, 10:318-323.
43. McLauchlan J, Lemberg M, Hope G, Martoglio B: Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. The EMBO journal 2002, 21(15):3980-3988.
44. Anand BS, Velez M: Assessment of correlation between serum titers of hepatitis c virus and severity of liver disease. World J Gastroenterol 2004, 15:2409-2411.
45. Beld M, Penning M, McMorrow M, Gorgels J, van den Hoek A, Goudsmit J: Different hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels. J Clin Microbiol 1998, 36:872-877.
46. Attallah AM, Ismail H, Tabll AA, Shiha GE, El-Dosoky I: A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection. J Immunoassay Immunochem 2003, 24(4):395-407.
47. Shiha GE, Zalata KR, Abdalla AF, Mohamed MK: Immunohistochemical identification of HCV target antigen in paraffin-embedded liver tissue: reproducibility and staining patterns. Liver Int 2005, 25(2):254-60.
48. Zhang YM, Li M, Dong WQ, Wu YS, Tian ZW, Wu XB: Cloning and expression of hepatitis C core protein gene. Di Yi Jun Yi Da Xue Xue Bao 2003, 23(10):1018-1020.
49. Choukhi A, Pillez A, Drobecq H, Sergheraert C, Wychowski C, Dubuisson J: Characterization of aggregates of hepatitis C virus glycoproteins. J Gen Virol 1999, 80:3099-107.